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Introduction {#ams2286-sec-0004}
============

Transarterial embolization (TAE) is an effective method for control of arterial bleeding associated with pelvic fractures,[1](#ams2286-bib-0001){ref-type="ref"}, [2](#ams2286-bib-0002){ref-type="ref"} and its use is recommended in several guidelines as the primary method of hemostasis for hemodynamically unstable patients.[3](#ams2286-bib-0003){ref-type="ref"}, [4](#ams2286-bib-0004){ref-type="ref"} The standard embolization technique in this context is total embolization of the bilateral internal iliac arteries, even if the bleeding source is unilateral.[5](#ams2286-bib-0005){ref-type="ref"} Several studies investigated ischemic complications after TAE in pelvic fracture patients, but no study has examined its effect on lower urinary tract symptoms (LUTS), specifically impaired urinary voiding and storage functions.

Recent studies reported that obstruction of bilateral iliac arteries in an animal model leads to bladder ischemia and results in overactivity and impaired contractility of the detrusor.[6](#ams2286-bib-0006){ref-type="ref"}, [7](#ams2286-bib-0007){ref-type="ref"} As the standard TAE technique for hemostasis of pelvic fractures resembles temporary total occlusion of the bilateral iliac arteries in the animal model, we presumed a possible relation between TAE and exacerbation of LUTS in the clinical setting. The objective of the study was to clarify the impact of TAE on LUTS in patients with pelvic fractures.

The protocol for this research project was approved by a suitably constituted Ethics Committee of the institution and it conformed to the provisions of the Declaration of Helsinki (Committee of Saitama Medical Center, Approval No. 1015). Written informed consent was obtained from all patients who participated in the study.

Cases {#ams2286-sec-0005}
=====

Among 432 traumatic pelvic fracture patients who were admitted to Saitama Medical Center (Saitama, Japan) from January 2004 to January 2014, 97 underwent TAE to control bleeding associated with the fractures. Seventy‐one patients with brain, spinal cord, vesical, and urethral injuries, or TAE of lumber arteries, which may affect lower urinary tract function, were excluded. In all, 26 patients were included in the study. The complete obstruction of the bilateral internal iliac arteries was achieved by catheterization and infusion of narrow slips of gelatin (Sponzel; Astellas Pharma, Tokyo, Japan), and the presence of bladder ischemia was confirmed by angiography. Lower urinary tract symptoms before and after TAE were evaluated by questionnaires, namely, the International Prostate Symptoms Score (IPSS), Overactive Bladder Symptoms Score (OABSS), and Quality Of Life (QOL) score. We sent the questionnaires to the 26 patients asking for participation, and 10 patients gave consent.

Table [1](#ams2286-tbl-0001){ref-type="table-wrap"}A shows age, sex, durations of unstable hemodynamics and urethral catheterization, and intervals between the evaluations. Our institutional criteria for implementation of the standard TAE included not only unstable hemodynamics, but also extravasation of the contrast media confirmed by enhanced computed tomography scan. According to the criteria, TAE was carried out in the six patients (\#2, 3, 4, 5, 8, and 10) who were hemodynamically stable.

###### 

Background characteristics and clinical courses related to lower urinary tract symptoms (A) and International Prostate Symptoms Score (IPSS), Overactive Bladder Symptoms Score (OABSS), and Quality of Life (QOL) score before and after transarterial embolization (TAE) (B) in pelvic fracture patients (*n* = 10)

  \(A\)                                                                               
  -------------- --------------- ----------- --------------- ------------- ---------- -----------------
  1              53              M           26              362           40         137
  2              55              M           26              0             28         61
  3              81              F           10              0             12         24
  4              49              M           42              0             9          183
  5              65              F           14              0             24         49
  6              72              M           19              33            7          98
  7              56              F           21              168           6          61
  8              83              M           17              0             7          31
  9              42              M           29              124           3          33
  10             77              M           10              0             7          58
  Median (IQR)   60 (54--74.5)   M : F 7:3   20 (15.5--26)   0 (0--78.5)   8 (7--8)   59.3 (41--79.5)

  \(B\)                                                                                                                                                   
  -------------- ---- ---- ------------------------------------------------------ --- ---- ------------------------------------------------------ --- --- ---------------------------------------------------
  1              0    14   14                                                     0   1    1                                                      0   6   6
  2              2    2    0                                                      3   6    3                                                      3   3   0
  3              2    5    3                                                      1   1    0                                                      1   3   2
  4              9    20   11                                                     0   1    1                                                      2   5   3
  5              6    7    1                                                      4   4    0                                                      2   2   0
  6              10   10   0                                                      3   3    0                                                      3   3   0
  7              3    3    0                                                      0   0    0                                                      1   1   0
  8              2    5    3                                                      0   10   10                                                     2   3   1
  9              2    3    1                                                      1   2    1                                                      1   1   0
  10             1    1    0                                                      1   1    0                                                      0   0   0
  Median (IQR)             +1.0 (0 to +3)[a](#ams2286-note-0002){ref-type="fn"}            +0.5 (0 to +1)[a](#ams2286-note-0002){ref-type="fn"}           0 (0 to +1)[a](#ams2286-note-0002){ref-type="fn"}

∆IPSS, ∆OABSS, and ∆QOL indicate changes in scores between evaluations. M, Male; F, Female; IQR, interquartile range.

Significant change (*P* \< 0.05) in score between evaluations.

John Wiley & Sons, Ltd

Table [1](#ams2286-tbl-0001){ref-type="table-wrap"}B shows IPSS, OABSS, and QOL, before and after TAE, and their changes (∆IPSS, ∆OABSS, and ∆QOL) in each case. All scores showed a significant increase (*P* \< 0.05) after TAE (Fig. [1](#ams2286-fig-0001){ref-type="fig"}).

![International Prostate Symptom Score (IPSS), Overactive Bladder Symptom Score (OABSS), and Quality Of Life (QOL) score before and after transarterial embolization (TAE) in 10 pelvic fracture patients, and their changes in each subject. \*Statistically significant change (*P* \< 0.05).](AMS2-4-358-g001){#ams2286-fig-0001}

Score changes for ∆IPSS, ∆OABSS, and ∆QOL were rated as: +1 (0 to +7) (median \[interquartile range\]), +1 (+0.5 to +2), and 0 (0 to +2), respectively, for men; and +1 (+0.5 to +2), 0 (0 to 0), and 0 (0 to +1), respectively, for women. The change in scores showed no significant difference (*P* \< 0.05) according to sex. Pearson\'s product‐moment correlation coefficients between ∆IPSS, ∆OABSS, and ∆QOL and age were −0.32, 0.32, and −0.19, respectively. Those between the scores and the injury severity score (ISS) were 0.55, 0.01, and 0.35, respectively. Those between the scores and the durations of unstable hemodynamics or urethral catheterization were 0.29, 0.18, and 0.19, or 0.40, 0.17, and 0.46, respectively. Those between the scores and the intervals were 0.75, −0.23, and 0.62, respectively. There was no significant correlation between changes in the scores and age, ISS, and durations. In contrast, there were significant positive correlations (*P* \< 0.05) between ∆IPSS or ∆QOL and the intervals (Fig. [2](#ams2286-fig-0002){ref-type="fig"}).

![Changes in the International Prostate Symptom Score (∆IPSS), Overactive Bladder Symptom Score (∆OABSS), and Quality Of Life (∆QOL) score before and after transarterial embolization (TAE) in 10 pelvic fracture patients plotted against intervals between the evaluations. Solid lines represent linear regression lines. Formulas indicate Pearson\'s product‐moment correlation coefficients and their *P*‐values.](AMS2-4-358-g002){#ams2286-fig-0002}

Discussion {#ams2286-sec-0006}
==========

The IPSS, OABSS, and QOL have verified validity in the evaluation of LUTS, and have been recommended for assessment of LUTS in clinical practice guidelines for both men and women.[8](#ams2286-bib-0008){ref-type="ref"}, [9](#ams2286-bib-0009){ref-type="ref"}

Both IPSS and OABSS showed a statistically significant worsening after TAE and the adverse impact of TAE on voiding and storage functions. Quality of Life scores also showed a significant worsening after TAE and indicated that urinary tract dysfunction after TAE adversely affected patients' quality of life. Exacerbation of IPSS, OABSS, and QOL showed no significant correlation with background characteristics and clinical courses such as sex, age, ISS, and durations of unstable hemodynamics and urethral catheterization. However, the exacerbation was significantly correlated with intervals between the evaluations. Given that the cases with prolonged intervals were relatively young (53 and 49 years old), the exacerbation was more attributable to TAE than aging. A study with an animal acute bladder ischemia and reperfusion model revealed the recovery of contractile function within 14 days.[10](#ams2286-bib-0010){ref-type="ref"} The intervals between evaluations were 24 days or longer in all patients who participated in this study. Taken together, the results may indicate that the exacerbation of LUTS and its impact on quality of life were persistent and possibly progressive.

None of the patients underwent magnetic resonance imaging to examine direct nerve injuries associated with pelvic fracture, and injuries could not be excluded as a cause for exacerbation of LUTS. Furthermore, the study did not compare the exacerbation in the TAE group with that in a non‐TAE or more selective TAE group. Therefore, the results only showed exacerbation of LUTS among the severe pelvic fracture patients treated with the standard TAE. However, taken together with the studies that reported lower urinary tract dysfunctions in animal models with obstruction of bilateral iliac arteries,[6](#ams2286-bib-0006){ref-type="ref"}, [7](#ams2286-bib-0007){ref-type="ref"} the results suggested that TAE might be one of the causes of exacerbation of LUTS in the patients.

The case series included six hemodynamically stable patients (\#2, 3, 4, 5, 8, and 10), who underwent standard TAE according to the institutional criteria and the Eastern Association for the Surgery of Trauma guidelines. The guidelines recommend TAE in patients with evidence of arterial intravenous contrast extravasation in the pelvis by computed tomography, regardless of their hemodynamic status.[3](#ams2286-bib-0003){ref-type="ref"} However, the guidelines do not refer to LUTS as a complication of TAE.

In these contexts, the development of LUTS should be noted as a complication of TAE in pelvic fracture patients, and the risk for developing LUTS has to be taken into consideration when deciding TAE in this patient population, as LUTS may have long‐term adverse impacts on function and quality of life. The decision to avoid standard TAE in hemodynamically unstable patients is difficult as it may risk their lives. However, when deciding TAE in hemodynamically stable patients, more selective or unilateral embolization may be considered to reduce the risk.
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